Rosso R - Search Results

1

Heterogeneity of the alpha-interferon-mediated overexpression of class-I and class-II major histocompatibility complex molecules in primary cultured cancer cells.

Semino C, Ferlazzo G, Pietra G, Pasquetti W, Repetto L, Rosso R, Mariani M, Melioli G. Semino C, et al. Among authors: rosso r. J Biol Regul Homeost Agents. 1993 Jul-Sep;7(3):99-105. J Biol Regul Homeost Agents. 1993. PMID: 8135147

2

Interferons in the treatment of advanced breast cancer.

Repetto L, Venturino A, Simoni C, Rosso M, Melioli G, Rosso R. Repetto L, et al. Among authors: rosso m, rosso r. J Biol Regul Homeost Agents. 1993 Oct-Dec;7(4):109-14. J Biol Regul Homeost Agents. 1993. PMID: 7517612 Review.

3

Lymphoblastoid interferon in advanced breast cancer: a phase II study.

Naso C, Simoni C, Merlini L, Rosso M, Pronzato P, Repetto L, Gardin G, Rosso R. Naso C, et al. Among authors: rosso m, rosso r. J Chemother. 1993 Aug;5(4):258-61. doi: 10.1080/1120009x.1993.11739241. J Chemother. 1993. PMID: 8229154 Clinical Trial.

4

Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapy.

Venturini M, Del Mastro L, Melioli G, Balleari E, Garrone O, Pasquetti W, Bason C, Ghio R, Bruzzi P, Rosso R. Venturini M, et al. Among authors: rosso r. Cancer. 1994 Oct 15;74(8):2300-6. doi: 10.1002/1097-0142(19941015)74:8<2300::aid-cncr2820740814>3.0.co;2-k. Cancer. 1994. PMID: 7522948

5

Tamoxifen and interferon-beta for the treatment of metastatic breast cancer.

Repetto L, Giannessi PG, Campora E, Pronzato P, Vigani A, Naso C, Spinelli I, Conte PF, Rosso R. Repetto L, et al. Among authors: rosso r. Breast Cancer Res Treat. 1996;39(2):235-8. doi: 10.1007/BF01806190. Breast Cancer Res Treat. 1996. PMID: 8872332 Clinical Trial.

6

Intraperitoneal chemotherapy with carboplatin and interferon alpha in the treatment of relapsed ovarian cancer: a pilot study.

Repetto L, Chiara S, Guido T, Bruzzone M, Oliva C, Ragni N, Conte PF, Rosso R. Repetto L, et al. Among authors: rosso r. Anticancer Res. 1991 Jul-Aug;11(4):1641-3. Anticancer Res. 1991. PMID: 1746921

7

Timed sequential chemotherapy following ifosfamide-induced kinetic recruitment in refractory ovarian cancer.

Rosso R, Alama A, Repetto L, Conte PF. Rosso R, et al. Cancer Chemother Pharmacol. 1990;26 Suppl:S43-4. doi: 10.1007/BF00685417. Cancer Chemother Pharmacol. 1990. PMID: 2347050

8

Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells.

Sobrero AF, Aschele C, Guglielmi AP, Mori AM, Melioli GG, Rosso R, Bertino JR. Sobrero AF, et al. Among authors: rosso r. J Natl Cancer Inst. 1993 Dec 1;85(23):1937-44. doi: 10.1093/jnci/85.23.1937. J Natl Cancer Inst. 1993. PMID: 8230285

9

Suramin and serum insulin-like growth factor levels in metastatic cancer patients.

Miglietta L, Barreca A, Repetto L, Costantini M, Rosso R, Boccardo F. Miglietta L, et al. Among authors: rosso r. Anticancer Res. 1993 Nov-Dec;13(6B):2473-6. Anticancer Res. 1993. PMID: 8135485

10

Vinorelbine as palliative therapy in advanced breast cancer.

Gasco M, Gardin G, Repetto L, Campora E, Rosso R. Gasco M, et al. Among authors: rosso r. Anticancer Res. 1997 Mar-Apr;17(2B):1431-3. Anticancer Res. 1997. PMID: 9137510

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

864 results

Search Page

Filters